Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin
Xuping Wu(Uppsala University), Simon Ekman(Karolinska University Hospital)
Cited by 61
Related Papers
Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
|Clinical Cancer Research|2012|382
Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells
|International Journal of Oncology|2012|19